These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 69574)

  • 1. [Clinical trial with long-term therapy of generalized plasmacytoma].
    Sakalová A; Gazová S; Makaiová I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(1):57-63. PubMed ID: 69574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity].
    Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J; Oravská D; Pokorná G; Mayer J
    Vnitr Lek; 1979 May; 25(5):425-35. PubMed ID: 452427
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up of certain immunologic indicators in the treatment of plasmacytoma with cyclophosphamide in combination with plasmapheresis.
    Sakalová A; Gazová S; Hrubisko M; Pokorná G; Mayer J
    Neoplasma; 1975; 22(1):63-7. PubMed ID: 807859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of thyroid-associated ophthalmopathy: comparative study between prednisone and COP therapy].
    Min HY; Liu XP; Jiang RX; Lian L; Hu TS
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):781-5. PubMed ID: 16191342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results and further perspectives of plasmocytoma chemotherapy.
    Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J
    Neoplasma; 1986; 33(2):251-8. PubMed ID: 3520353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience in the diagnosis and therapy of plasmacytoma (author's transl)].
    Kahler OH
    Wien Med Wochenschr; 1979 Feb; 129(4):101-6. PubMed ID: 425546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
    Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic plasmapheresis in the treatment of plasmacytoma].
    Quietzsch D; Kaltofen G; Eichhorn K
    Z Gesamte Inn Med; 1981 Apr; 36(8):308-10. PubMed ID: 7281836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
    van Agthoven M; Wittebol S; Budel LM; Uyl-de Groot CA; Kramer MH
    Ned Tijdschr Geneeskd; 2004 Jan; 148(2):88-93. PubMed ID: 14753131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with cytostatic therapy of stomach cancer].
    Kuklis B; Iliás L; Simig M; Sebesi J; Pattantyus J; Fiala E
    Orv Hetil; 1991 Aug; 132(31):1691-4. PubMed ID: 1866164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
    Kalinka-Warzocha E; Wajs J; Lech-Maranda E; Ceglarek B; Holowiecki J; Federowicz I; Walewski J; Czyz J; Robak T; Warzocha K;
    Cancer; 2008 Jul; 113(2):367-75. PubMed ID: 18470902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B
    J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of serum BuChe activity during polychemotherapy based on COP and C-MOPP protocols].
    Fazio M; Airoldi M; Bellardo A; Cavallero P; Mastromatteo V; Minnella R; Pecchio F
    Boll Soc Ital Biol Sper; 1981 Dec; 57(24):2512-8. PubMed ID: 7337762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.
    Danieli MG; Cappelli M; Malcangi G; Logullo F; Salvi A; Danieli G
    Ann Rheum Dis; 2004 Dec; 63(12):1649-54. PubMed ID: 15547090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myeloma maintenance regimen of prednisone. Adriamycin, imuran, and vincristine in a murine plasmacytoma model.
    Ghanta VK; Cohen HJ; Silberman HR; Durant JR; Hiramoto RN
    Cancer Clin Trials; 1981; 4(2):135-41. PubMed ID: 7249251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.